Get the app!
Back to Trades

Baranowski Lyn

Chief Executive OfficerDirectorCIK 0001893640

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
5
Companies
1
Active
2026

Across 3 filings between 2026, Baranowski Lyn, Chief Executive Officer, Director, has disclosed $11.0M in transactions — all concentrated in Avalyn Pharma Inc. (AVLN). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.5M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Nov 19AVLN
Avalyn Pharma Inc.
Baranowski LynChief Executive Officer, DirectorSell$1.5M
May 1AVLN
Avalyn Pharma Inc.
Baranowski LynInsiderAward$9.0M
Apr 29AVLN
Avalyn Pharma Inc.
Baranowski LynInsiderOther$0

3 filings